90 related articles for article (PubMed ID: 20058865)
1. Inhibitors of prolyl oligopeptidases for the therapy of human diseases: defining diseases and inhibitors.
Lawandi J; Gerber-Lemaire S; Juillerat-Jeanneret L; Moitessier N
J Med Chem; 2010 May; 53(9):3423-38. PubMed ID: 20058865
[No Abstract] [Full Text] [Related]
2. The natural product berberine is a human prolyl oligopeptidase inhibitor.
Tarrago T; Kichik N; Seguí J; Giralt E
ChemMedChem; 2007 Mar; 2(3):354-9. PubMed ID: 17295371
[TBL] [Abstract][Full Text] [Related]
3. Benzimidazolium salts as small, nonpeptidic and BBB-permeable human prolyl oligopeptidase inhibitors.
Tarragó T; Masdeu C; Gómez E; Isambert N; Lavilla R; Giralt E
ChemMedChem; 2008 Oct; 3(10):1558-65. PubMed ID: 18792035
[TBL] [Abstract][Full Text] [Related]
4. Extracellular proteases and their inhibitors in genetic diseases of the central nervous system.
Molinari F; Meskanaite V; Munnich A; Sonderegger P; Colleaux L
Hum Mol Genet; 2003 Oct; 12 Spec No 2():R195-200. PubMed ID: 12925575
[TBL] [Abstract][Full Text] [Related]
5. [Molecular modeling studies of prolyl endopeptidase inhibitors].
Kánai K; Fehér M; Lopata A; Podányi B; Novák I; Susán E; Hermecz I; Arányi P
Acta Pharm Hung; 1999 Nov; 69(5):240-6. PubMed ID: 10652791
[TBL] [Abstract][Full Text] [Related]
6. [Neuroleptic catalepsy in rats is accompanied by activation of brain prolyl endopeptidase and is eliminated by inhibitors of this enzyme].
Narkevich VB; Nazarova GA; Zolotov NN; Pozdnev VF; Raevskiĭ KS
Dokl Akad Nauk; 1994 Dec; 339(5):691-3. PubMed ID: 7874014
[No Abstract] [Full Text] [Related]
7. Pyrrolidinyl pyridone and pyrazinone analogues as potent inhibitors of prolyl oligopeptidase (POP).
Haffner CD; Diaz CJ; Miller AB; Reid RA; Madauss KP; Hassell A; Hanlon MH; Porter DJ; Becherer JD; Carter LH
Bioorg Med Chem Lett; 2008 Aug; 18(15):4360-3. PubMed ID: 18606544
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic applications of chymase inhibitors in cardiovascular diseases and fibrosis.
Takai S; Jin D; Muramatsu M; Okamoto Y; Miyazaki M
Eur J Pharmacol; 2004 Oct; 501(1-3):1-8. PubMed ID: 15464056
[TBL] [Abstract][Full Text] [Related]
9. [Prolyl endopeptidase inhibitors].
Aoyagi T; Muraoka Y
Tanpakushitsu Kakusan Koso; 1993 Aug; 38(11):1971-86. PubMed ID: 8210438
[No Abstract] [Full Text] [Related]
10. [Protease inhibitors against hepatitis C].
Holzgrabe U
Pharm Unserer Zeit; 2004; 33(3):160-1. PubMed ID: 15208903
[No Abstract] [Full Text] [Related]
11. Inhibitors of serine proteases as potential therapeutic agents: the road from thrombin to tryptase to cathepsin G.
Maryanoff BE
J Med Chem; 2004 Feb; 47(4):769-87. PubMed ID: 14761180
[No Abstract] [Full Text] [Related]
12. Mechanism of interaction of cysteine proteinases and their protein inhibitors as compared to the serine proteinase-inhibitor interaction.
Bode W; Engh R; Musil D; Laber B; Stubbs M; Huber R; Turk V
Biol Chem Hoppe Seyler; 1990 May; 371 Suppl():111-8. PubMed ID: 2205234
[No Abstract] [Full Text] [Related]
13. Tryptase inhibitors in the treatment of pulmonary diseases.
Gangloff AR
Curr Opin Investig Drugs; 2000 Sep; 1(1):79-85. PubMed ID: 11249600
[No Abstract] [Full Text] [Related]
14. A cyclopent-2-enecarbonyl group mimics proline at the P2 position of prolyl oligopeptidase inhibitors.
Jarho EM; Venäläinen JI; Huuskonen J; Christiaans JA; Garcia-Horsman JA; Forsberg MM; Järvinen T; Gynther J; Männistö PT; Wallén EA
J Med Chem; 2004 Nov; 47(23):5605-7. PubMed ID: 15509157
[TBL] [Abstract][Full Text] [Related]
15. [Serine proteases and their inhibitors: their role in the differentiation in neuromuscular system].
Hantaï D; Akaaboune M; Verdière-Sahuqué M; Lachkar S; Festoff BW
C R Seances Soc Biol Fil; 1994; 188(5-6):541-52. PubMed ID: 7780796
[TBL] [Abstract][Full Text] [Related]
16. Dicarboxylic acid azacycle l-prolyl-pyrrolidine amides as prolyl oligopeptidase inhibitors and three-dimensional quantitative structure-activity relationship of the enzyme-inhibitor interactions.
Jarho EM; Wallén EA; Christiaans JA; Forsberg MM; Venäläinen JI; Männistö PT; Gynther J; Poso A
J Med Chem; 2005 Jul; 48(15):4772-82. PubMed ID: 16033257
[TBL] [Abstract][Full Text] [Related]
17. Novel inhibitors of prolyl endopeptidase: effects of stereochemistry.
Kolosko N; Bakker AV; Faraci WS; Nagel AA
Drug Des Discov; 1994 Jan; 11(1):61-71. PubMed ID: 8068820
[TBL] [Abstract][Full Text] [Related]
18. A new side opening on prolyl oligopeptidase revealed by electron microscopy.
Tarragó T; Martín-Benito J; Sabidó E; Claasen B; Madurga S; Gairí M; Valpuesta JM; Giralt E
FEBS Lett; 2009 Oct; 583(20):3344-8. PubMed ID: 19782684
[TBL] [Abstract][Full Text] [Related]
19. Compensatory proteolytic responses to dietary proteinase inhibitors in the red flour beetle, Tribolium castaneum (Coleoptera: Tenebrionidae).
Oppert B; Morgan TD; Hartzer K; Kramer KJ
Comp Biochem Physiol C Toxicol Pharmacol; 2005 Jan; 140(1):53-8. PubMed ID: 15792623
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of human leukocyte proteinase 3 by a novel recombinant serine proteinase inhibitor (LEX032).
Groutas WC; Ruan S; Kuang R; Hook JB; Sands H
Biochem Biophys Res Commun; 1997 Apr; 233(3):697-9. PubMed ID: 9168917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
